Analysis of the latest domestic and international prices and regular purchase channels of odevixibat

Odevixibat (Odevixibat) is a new oral drug mainly used to treat hereditary cholestatic liver disease (PFIC) and other diseases related to abnormal bile metabolism in children and adults. This drug reduces bile acid reabsorption by inhibiting the small intestinal bile acid transporter (IBAT/ASBT), thereby reducing serum bile acid levels and improving itching symptoms. Clinically, odexibat can significantly improve patients' quality of life, especially relieving stubborn itching caused by cholestasis.

In the domestic market, Odesibat is already on the market, but it has not yet been included in the medical insurance system, so patients need to bear all the drug costs. Since there is no large-scale medical insurance reimbursement in China and drug prices are relatively high, patients should obtain them through regular pharmacy or hospital channels when purchasing to ensure drug quality and safety. When prescribing medicine, doctors usually combine the patient's condition, weight and liver function indicators to formulate an individualized dosage plan to ensure the therapeutic effect.

In overseas markets, the specifications of the original drug Odesibate are200mcg30 tablets, and the price per box may be as high as more than 40,000 yuan. The price is greatly affected by exchange rate fluctuations and regional differences. At the same time, Lao version of generic drugs has also appeared in overseas markets, providing patients with a more economical choice. For example, the price of 400mcg30 tablets or 1200mcg30 generic odixibat generic drugs produced by Laos Lucius is about RMB 3,000, while the price of generic drugs of 200mcg30 tablets or 1200mcg30 tablets produced by ASEAN Pharmaceuticals in Laos is about RMB 500. Generic drugs are basically the same as the original drugs in terms of drug ingredients and can meet the basic medication needs of patients.

Generally speaking, although odixibat is already on the market in China, it is not included in medical insurance and is relatively expensive. However, generic drugs in overseas markets provide more affordable alternatives. When choosing a purchase channel, patients should comprehensively consider drug accessibility, price, legality and doctor's advice, and give priority to purchasing through formal channels to ensure drug safety and treatment continuity.

Reference materials:https://www.drugs.com/